Parathyroid suppressibility in renal osteodystrophy.
作者信息
Moorhead J F, Varghese Z, Tatler G L, Baillod R A, Ku G, Sweatman A J, Wills M R
出版信息
Proc Eur Dial Transplant Assoc. 1975;11:465-72.
PMID:1197271
Abstract
摘要
相似文献
1
Parathyroid suppressibility in renal osteodystrophy.肾性骨营养不良中的甲状旁腺抑制性
Proc Eur Dial Transplant Assoc. 1975;11:465-72.
2
Plasma hydroxyproline in renal osteodystrophy.肾性骨营养不良中的血浆羟脯氨酸
Proc Eur Dial Transplant Assoc. 1973;10(0):187-96.
3
Osteodystrophy of dialysed patients treated with vitamin D.
Proc Eur Dial Transplant Assoc. 1973;10(0):217-26.
4
1,25-dihydroxycholecalciferol in patients with chronic renal failure.
Proc Eur Dial Transplant Assoc. 1973;10(0):202-9.
5
Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?降钙素在控制肾性骨营养不良方面是磷结合剂的辅助药物吗？
Nephrol Dial Transplant. 1995;10(9):1782.
6
Parathyroid function in uremic children with and without osteodystrophy.患有和未患骨营养不良的尿毒症儿童的甲状旁腺功能
Pediatrics. 1974 Mar;53(3):404-9.
7
Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.维持性血液透析患者的血清羟脯氨酸与肾性骨营养不良
N Z Med J. 1974 Dec 25;80(530):540-4.
8
Treatment of renal osteodystrophy with 1alpha-hydroxycholecalciferol (1alpha-OH-D3) in conjunction with a high dialysate calcium.
Calcif Tissue Res. 1977 May;22 Suppl:94-100. doi: 10.1007/BF02064047.
9
Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
Contrib Nephrol. 1980;18:55-71. doi: 10.1159/000403273.
10
1,25(OH)2D3 and 25-OHD3 in the treatment of renal osteodystrophy: comparison of combined versus 1,25(OH)2D3 administration alone.
Miner Electrolyte Metab. 1983 Jan-Feb;9(1):19-27.
Zotero 插件